Dr. Daniele Gemma
I am Dr. Daniele Gemma, a hemodynamic cardiologist who works in the Hemodynamics Unit of the UICAR.
After graduating in Medicine and Surgery from the University of Pavia (Italy), I completed 5 years of Cardiology residency at La Paz University Hospital, at the end of which I continued training in Hemodynamics and Interventional Cardiology for another two years. years, during which in addition to learning the trade of hemodynamics and carrying out healthcare activities, I have been able to develop research projects at a national and international level. After my training period and work experiences in public hospitals in Madrid, in 2017 I began my collaboration with the cardiology team at Hospital la Luz and I am currently fortunate to be part of the UICAR team.
Most of my work activity is currently carried out in Hemodynamics, dedicating myself in particular to the percutaneous treatment of both acute and chronic coronary artery disease. Our unit is responsible for the diagnosis, treatment and monitoring of patients with ischemic heart disease, having the latest technical provisions and material that allows effective and safe treatment in all types of scenarios. We care from high-risk acute infarctions that require urgent interventions, to patients with advanced and complex chronic coronary disease, such as severely calcified lesions or chronic coronary occlusions, participating in clinical trials and national and international registries.
In addition to coronary pathology, we are also dedicated to what we know as “structural heart disease”, performing everything from percutaneous closure of interatrial communications, to closure of left atrial appendages and, above all, to the implantation of percutaneous aortic prosthesis (TAVI).
Another fundamental objective of our hemodynamics unit is to offer comprehensive follow-up of our patients, both before and after catheterizations, also carrying out an important activity of clinical consultations and non-invasive tests, in order to offer the treatment and long-term follow-up they need. our patients.